The Buck Institute's Dr. Kennedy led a team earlier this year that found that another form of rapamycin was effective in increasing the life spans and improving symptoms in mice with two different diseases caused by other mutations in the progeria-connected Lamin A gene.
WSJ: Progeria Drug Study Helps in Search for Clues on Aging